Effect of methotrexate on the development of lymphoma in rheumatoid arthritis patients

Effect of methotrexate on the development of lymphoma in rheumatoid arthritis patients - Effect of methotrexate on the development of lymphoma in rheumatoid arthritis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040712

Enrollment

20000

Registered

2020-06-11

Start date

2019-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosis of RA on our database.

Exclusion criteria

Exclusion criteria: Not diagnosis of RA on our database.

Design outcomes

Primary

Measure	Time frame
Analysis of rheumatoid arthritis (RA) patients who developed lymphoma between those treated by methotrexate (MTX) treatment and by non-MTX treatment.	—

Countries

Japan

Contacts

Public ContactNoboru Kitamura

Nihon University School of Medicine Division of Hematology and Rheumatology, Department of Medicine

kitamura.noboru@nihon-u.ac.jp03-3972-8111

Outcome results